Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year end trading update & dividend declaration

11 Apr 2011 07:00

RNS Number : 6290E
e2v technologies PLC
11 April 2011
 



 

11 April 2011

e2v technologies plc

 

 

2011 Year end trading update and dividend declaration

 

 

e2v technologies plc, the specialist provider of technology solutions for high performance systems, is today providing a period end trading update for the financial year ended 31 March 2011.

Highlights

 

·; Full year trading performance expected to be ahead of management's previous expectations

·; Over 9% underlying turnover growth, 13% reported

·; Excellent progress in developing key new application areas

·; Net borrowings of c.£28m, lower than previous expectations

·; Intended full year dividend of 3.6 pence a share

 

Keith Attwood, Chief Executive Officer, said

 

"We are very pleased to have delivered such a strong trading performance in improving markets overall and believe the business is well positioned to deliver further growth. As a result, the Board has decided to restart the payment of dividends earlier than planned.

 

During the year we have made continued progress on implementing the growth strategy, previously announced last July. We intend to provide further guidance on the scale of the opportunities being generated when we announce our results on 6 June."

 

 

Group Performance and Strategy Summary

 

Group revenue for the financial year ended 31 March 2011 was around £229m, up by over 13% compared with last financial year. The Group's trading performance for the full year is anticipated to be ahead of management's previous expectations.

 

Underlying turnover growth for the Group's continuing products (see note 3) was over 9%.

 

Interest expense in the financial year ended 31 March 2011 is anticipated to be around £4.5m and our adjusted effective tax rate for the year is estimated to be c.31%.

 

The growth strategy we announced on 26 July 2010 set out our focus on:

 

·; Six existing application areas, which represented two thirds of our base business

·; Two new focus areas of semiconductor lifecycle management and bulk materials processing

·; Geographic expansion in the US and Asia.

 

The growth strategy also set out our financial targets:

 

·; 15% underlying operating profit margin before December 2012

·; 8% a year underlying revenue growth by July 2013.

 

We believe we are currently ahead of these financial targets, by approximately 12 and 18 months respectively.

 

 

Divisional performance in the financial year ended 31 March 2011

 

In RF Power Solutions, our radiotherapy sales grew strongly. Our engagement in electronic countermeasures in the US is building, with a further contract award received within an ongoing military fast jet programme as well as a new development contract for our ultrawide band travelling wave tube on an airborne upgrade programme. In Europe, we have experienced lower demand as anticipated within electronic countermeasures. The other product lines in the division grew overall, with strong revenue growth in industrial products offsetting modest decline elsewhere.

 

In bulk materials processing, we have secured orders in the year of c.£1m for development work with our customers in the mining and offshore oil drilling sectors. Equipment orders for full scale production trials are anticipated to be received in the coming quarter. We will be demonstrating our 'production-ready' machine for vermiculite processing to members of The Vermiculite Association in April. We are also seeking to accelerate the technology for this programme and so have submitted an application to the Regional Growth Fund.

 

In High Performance Imaging Solutions, demand for our industrial process control cameras continued to be very strong, due to demand from Asia, along with recovering demand in our scientific imaging products. Progress has continued on resolving technical issues within our space imaging activities, though certain programmes remain challenging. Other product lines, including dental products, benefited from last time buy activity and have shown underlying growth on the smaller continuing product portfolio.

 

In Hi-Rel Semiconductor Solutions, the contract to support semiconductor lifecycle management for the 68k series microprocessor for the Eurofighter Typhoon programme secured revenues estimated at £30m over the next 10 years, of which £16m has been delivered this year, resulting in strong revenue growth in the year. The European assembly and test services business grew, offsetting lower assembly activity in the US operations due primarily to lower European end user demand.

 

In the US, we have partnered with Raytheon Space and Airline Systems to provide semiconductor lifecycle management services to support the F15 radar system. This contract will be for the next 5 years with an initial estimated value of £3m. We are also developing a broad range of other programmes with Raytheon and other leading defence OEMs in the US. These have a potential contract value of c.£35m over a 5 year period.

 

With the situation in Japan, we have taken management action to seek to secure our supply chain including extending forward orders. We do not currently anticipate material supply chain disruption to our planned revenue in the financial year ending 31 March 2012.

 

 

Order Book

 

The Group's total order book is £167m (31 March 2010: £161m), whilst the order book for delivery over the coming 12 months is £137m (31 March 2010: £132m). The order book includes last time buy orders of £7.8m (31 March 2010: £12.5m).

 

 

Net Borrowings

 

Net borrowings at 31 March 2011 were approximately £28m, a reduction of £17m from net borrowings of £45m at 31 March 2010.

 

  

Restructuring Programme and Organisational Changes

 

The restructuring programme has continued to plan and is now complete in the UK. In France, the programme is largely complete, with the front end CCD fab on schedule to close in June.

 

Consistent with previous communications, we have also completed the review of the activities held in the corporate centre. As a result, we have transferred the hand held thermal imaging product line to our High Performance Imaging Solutions division. The remaining businesses, equating to 6% of turnover, are confirmed as non core activities.

 

 

Dividend

 

Following the announcement on 20 January 2011, the Board is today pleased to confirm its intention to return to a progressive dividend policy. For the financial year ended 31 March 2011, the Board intends to pay a dividend of 3.6 pence per share. Of this, 1.2 pence per share will be paid on 27 May 2011 to e2v shareholders on the register as at 3 May 2011 and, subject to e2v shareholder approval at the Group's forthcoming Annual General Meeting, 2.4 pence per share will be paid on 3 August 2011 to e2v shareholders on the register as at 8 July 2011. Barring exceptional circumstances, the Board intends to adopt a similar weighting between interim and final dividends in future financial years.

 

 

 

Further enquiries:

e2v technologies plc Tel: +44 (0)1245 493 493

Keith Attwood/Charles Hindson

www.e2v.com

 

Financial Dynamics Tel: +44 (0)20 7269 7291

Nick Hasell/Nina Delangle

 

 

Notes to editors

 

1. The full year results will be announced on Monday 6 June 2011.

2. Net borrowings exclude capitalised borrowing costs.

3. The continuing products exclude "one off" revenue in the year, arising mainly from last time buys on the Grenoble front end fab, and non core product areas to our strategy, mainly servicing the automotive sector.

4. All financial information included in this release is sourced from unaudited management accounts and excludes any exceptional items.

5. Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect the Group's current expectations concerning future events and actual results may differ materially from current expectations or historical results.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDSRUGBGBI
Date   Source Headline
3rd Jan 20144:37 pmRNSHolding(s) in Company
5th Dec 201311:42 amRNSAdditional Listing
27th Nov 201311:35 amRNSGeneral Meeting
19th Nov 20134:25 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
14th Nov 20133:27 pmRNSNotification of Major Interest in Shares
14th Nov 201312:49 pmRNSNotice of General Meeting
6th Nov 20134:57 pmRNSTransaction in Own Shares
4th Nov 201311:44 amRNSDirector/PDMR Shareholding
4th Nov 20137:00 amRNSHalf-year results for six months to 30 Sept 2013
18th Oct 20137:00 amRNSAppointment of Chief Executive
15th Oct 20137:00 amRNSPeriod end update
14th Oct 20134:15 pmRNSHolding(s) in Company
1st Oct 20134:51 pmRNSTransaction in Own Shares
27th Sep 20134:18 pmRNSPurchase of Own Shares
23rd Sep 20134:00 pmRNSShare buy-back programme
19th Aug 20132:15 pmRNSTotal Voting Rights
13th Aug 20134:15 pmRNSHolding(s) in Company
13th Aug 20131:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20137:00 amRNSDirector/PDMR Shareholding
19th Jul 20137:00 amRNSAwards under Long Term Incentive Plan
17th Jul 20131:45 pmRNSAnnual General Meeting 2013
17th Jul 20137:00 amRNSDirectorate Change
17th Jul 20137:00 amRNSInterim Management Statement
1st Jul 20134:35 pmRNSHolding(s) in Company
26th Jun 20134:29 pmRNSHolding(s) in Company
26th Jun 201311:11 amRNSHolding(s) in Company
12th Jun 201312:00 pmRNSDirectorate Change
20th May 20132:20 pmRNSDirector/PDMR Shareholding
20th May 20137:00 amRNSResults for the year ended 31 March 2013
25th Apr 20133:58 pmRNSNotification of Major Interest in Shares
22nd Apr 20135:00 pmRNSNotification of Major Interest in Shares
16th Apr 20137:00 amRNSTrading Statement
9th Apr 201310:00 amRNSTotal Voting Rights
18th Mar 20134:00 pmRNSNotification of Major Interest in Shares
18th Mar 20137:00 amRNSe2v wins ?10m ESA space science contract
6th Mar 20133:11 pmRNSHolding(s) in Company
6th Mar 20132:15 pmRNSHolding(s) in Company
5th Mar 20137:00 amRNSContract Renewal
22nd Feb 20132:02 pmRNSNotification of Major Interest in Shares
14th Feb 201311:00 amRNSDirector/PDMR Shareholding
12th Feb 20134:43 pmRNSDirector/PDMR Shareholding
12th Feb 201311:10 amRNSHolding(s) in Company
11th Feb 20134:13 pmRNSTotal Voting Rights
11th Feb 20137:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20137:00 amRNSInterim Management Statement
8th Jan 201311:40 amRNSTotal Voting Rights
7th Jan 20131:59 pmRNSDirector/PDMR Shareholding
7th Dec 20127:00 amRNSContract Renewal
3rd Dec 20127:00 amRNSSale of land
30th Nov 20123:39 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.